Immune Checkpoint Inhibitor-Induced Limbic Encephalitis during Treatment with Atezolizumab in a Patient with Small-Cell Lung Cancer: A Case Report and Review of the Literature

Paraneoplastic neurological syndrome (PNS) is associated with malignancies, including small-cell lung cancer. Recently, PNS cases among patients with small-cell lung cancer (SCLC) induced by immune checkpoint inhibitors have increased. We herein report a 66-year-old man with SCLC who developed disor...

Full description

Saved in:
Bibliographic Details
Main Authors: Koki Nakashima, Yoshiki Demura, Kosuke Kurokawa, Toshihiro Takeda, Norihiro Jikuya, Masahiro Oi, Toshihiko Tada, Masaya Akai, Tamotsu Ishizuka
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:Case Reports in Immunology
Online Access:http://dx.doi.org/10.1155/2022/9290922
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832559133758324736
author Koki Nakashima
Yoshiki Demura
Kosuke Kurokawa
Toshihiro Takeda
Norihiro Jikuya
Masahiro Oi
Toshihiko Tada
Masaya Akai
Tamotsu Ishizuka
author_facet Koki Nakashima
Yoshiki Demura
Kosuke Kurokawa
Toshihiro Takeda
Norihiro Jikuya
Masahiro Oi
Toshihiko Tada
Masaya Akai
Tamotsu Ishizuka
author_sort Koki Nakashima
collection DOAJ
description Paraneoplastic neurological syndrome (PNS) is associated with malignancies, including small-cell lung cancer. Recently, PNS cases among patients with small-cell lung cancer (SCLC) induced by immune checkpoint inhibitors have increased. We herein report a 66-year-old man with SCLC who developed disorientation, dysphagia, and gait disturbance after three courses of treatment with atezolizumab. Brain magnetic resonance imaging revealed a high-intensity area in the bilateral temporal lobes. Blood test results were positive for anti-Hu and anti-Zic4 antibodies, which led to the diagnosis of limbic encephalitis as PNS. Some symptoms improved with intravenous administration of steroids and immunoglobulins.
format Article
id doaj-art-4bbaf35b4b784f888a049fea14c3ecd0
institution Kabale University
issn 2090-6617
language English
publishDate 2022-01-01
publisher Wiley
record_format Article
series Case Reports in Immunology
spelling doaj-art-4bbaf35b4b784f888a049fea14c3ecd02025-02-03T01:30:39ZengWileyCase Reports in Immunology2090-66172022-01-01202210.1155/2022/9290922Immune Checkpoint Inhibitor-Induced Limbic Encephalitis during Treatment with Atezolizumab in a Patient with Small-Cell Lung Cancer: A Case Report and Review of the LiteratureKoki Nakashima0Yoshiki Demura1Kosuke Kurokawa2Toshihiro Takeda3Norihiro Jikuya4Masahiro Oi5Toshihiko Tada6Masaya Akai7Tamotsu Ishizuka8Depertment of Respiratory MedicineDepertment of Respiratory MedicineDepertment of Respiratory MedicineDepertment of Respiratory MedicineDepertment of Respiratory MedicineDepertment of Respiratory MedicineDepertment of Respiratory MedicineDepertment of Respiratory MedicineThird Department of Internal MedicineParaneoplastic neurological syndrome (PNS) is associated with malignancies, including small-cell lung cancer. Recently, PNS cases among patients with small-cell lung cancer (SCLC) induced by immune checkpoint inhibitors have increased. We herein report a 66-year-old man with SCLC who developed disorientation, dysphagia, and gait disturbance after three courses of treatment with atezolizumab. Brain magnetic resonance imaging revealed a high-intensity area in the bilateral temporal lobes. Blood test results were positive for anti-Hu and anti-Zic4 antibodies, which led to the diagnosis of limbic encephalitis as PNS. Some symptoms improved with intravenous administration of steroids and immunoglobulins.http://dx.doi.org/10.1155/2022/9290922
spellingShingle Koki Nakashima
Yoshiki Demura
Kosuke Kurokawa
Toshihiro Takeda
Norihiro Jikuya
Masahiro Oi
Toshihiko Tada
Masaya Akai
Tamotsu Ishizuka
Immune Checkpoint Inhibitor-Induced Limbic Encephalitis during Treatment with Atezolizumab in a Patient with Small-Cell Lung Cancer: A Case Report and Review of the Literature
Case Reports in Immunology
title Immune Checkpoint Inhibitor-Induced Limbic Encephalitis during Treatment with Atezolizumab in a Patient with Small-Cell Lung Cancer: A Case Report and Review of the Literature
title_full Immune Checkpoint Inhibitor-Induced Limbic Encephalitis during Treatment with Atezolizumab in a Patient with Small-Cell Lung Cancer: A Case Report and Review of the Literature
title_fullStr Immune Checkpoint Inhibitor-Induced Limbic Encephalitis during Treatment with Atezolizumab in a Patient with Small-Cell Lung Cancer: A Case Report and Review of the Literature
title_full_unstemmed Immune Checkpoint Inhibitor-Induced Limbic Encephalitis during Treatment with Atezolizumab in a Patient with Small-Cell Lung Cancer: A Case Report and Review of the Literature
title_short Immune Checkpoint Inhibitor-Induced Limbic Encephalitis during Treatment with Atezolizumab in a Patient with Small-Cell Lung Cancer: A Case Report and Review of the Literature
title_sort immune checkpoint inhibitor induced limbic encephalitis during treatment with atezolizumab in a patient with small cell lung cancer a case report and review of the literature
url http://dx.doi.org/10.1155/2022/9290922
work_keys_str_mv AT kokinakashima immunecheckpointinhibitorinducedlimbicencephalitisduringtreatmentwithatezolizumabinapatientwithsmallcelllungcanceracasereportandreviewoftheliterature
AT yoshikidemura immunecheckpointinhibitorinducedlimbicencephalitisduringtreatmentwithatezolizumabinapatientwithsmallcelllungcanceracasereportandreviewoftheliterature
AT kosukekurokawa immunecheckpointinhibitorinducedlimbicencephalitisduringtreatmentwithatezolizumabinapatientwithsmallcelllungcanceracasereportandreviewoftheliterature
AT toshihirotakeda immunecheckpointinhibitorinducedlimbicencephalitisduringtreatmentwithatezolizumabinapatientwithsmallcelllungcanceracasereportandreviewoftheliterature
AT norihirojikuya immunecheckpointinhibitorinducedlimbicencephalitisduringtreatmentwithatezolizumabinapatientwithsmallcelllungcanceracasereportandreviewoftheliterature
AT masahirooi immunecheckpointinhibitorinducedlimbicencephalitisduringtreatmentwithatezolizumabinapatientwithsmallcelllungcanceracasereportandreviewoftheliterature
AT toshihikotada immunecheckpointinhibitorinducedlimbicencephalitisduringtreatmentwithatezolizumabinapatientwithsmallcelllungcanceracasereportandreviewoftheliterature
AT masayaakai immunecheckpointinhibitorinducedlimbicencephalitisduringtreatmentwithatezolizumabinapatientwithsmallcelllungcanceracasereportandreviewoftheliterature
AT tamotsuishizuka immunecheckpointinhibitorinducedlimbicencephalitisduringtreatmentwithatezolizumabinapatientwithsmallcelllungcanceracasereportandreviewoftheliterature